Header Ads


Slide and Poster Presentation at the American Academy of Neurology Meeting by Ultragenyx

Ultragenyx, the bio-pharmaceutical company conducting the clinical trial with Sialic Acid -extended release and immediate release has announced positive data from their phase 2 study,  The company presented some of this information prior to this, however the data now seems to have more details.

I hope the graphs and charts I have posted here are legible. Please feel  free to contact me if you have any questions.                                                

No comments:

Powered by Blogger.